Alpha-synuclein dosage methods in the various forms of Parkinson's

it

Prof. Alfredo Berardelli

Alzheimer, which clinical and organizational perspectives for the new monoclonals

it

Prof. Alessandro Padovani

Possible applications of AI in management of neurological diseases

it

Prof. Stefano F. Cappa

Neurological complications from Covid-19: incidence and sequelae

it

Prof. Carlo Ferrarese

MS: many therapies available today. The challenge is to customize treatments

it

Prof. Massimo Filippi

Sleep quality and neurodegenerative diseases

it

Prof. Giuseppe Plazzi

Neuromuscular diseases: a rapidly evolving therapeutic landscape

it

Prof. Antonio Toscano

ALS management, valuable support from AI and Machine Learning

it

Prof. Vincenzo Silani

Identifying patients with preclinical forms of Alzheimer's

it

Prof. Camillo Marra

Migraine: the evolution of anti-CGRP monoclonal antibodies

it

Prof. Antonio Russo